OUR PIPELINE

Progress in Research & Development

Vyera collaborates with a global team of medical specialists and scientists to aid in the advancement of its pipeline of novel small molecule therapeutics. In addition to focusing on conventional therapeutic approaches, Vyera has committed to developing new paradigms to address diseases through the evaluation of innovative delivery and formulation technologies, while also exploring novel mechanisms of action.

Product

Preclinical

Phase I

Phase II

Phase III

Marketed

Efficiency
92%
Customer Satisfaction
98%